Cargando…
Patient Perceptions and Potential Utility of Pharmacogenetic Testing in Chronic Pain Management and Opioid Use Disorder in the Camden Opioid Research Initiative
Pharmacogenetics (PGx) has the potential to improve opioid medication management. Here, we present patient perception data, pharmacogenetic data and medication management trends in patients with chronic pain (arm 1) and opioid use disorder (arm 2) treated at Cooper University Health Care in Camden C...
Autores principales: | Kusic, Dara, Heil, Jessica, Zajic, Stefan, Brangan, Andrew, Dairo, Oluseun, Smith, Gretchen, Morales-Scheihing, Diego, Buono, Russell J., Ferraro, Thomas N., Haroz, Rachel, Salzman, Matthew, Baston, Kaitlan, Bodofsky, Elliot, Sabia, Michael, Resch, Alissa, Scheinfeldt, Laura B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505214/ https://www.ncbi.nlm.nih.gov/pubmed/36145611 http://dx.doi.org/10.3390/pharmaceutics14091863 |
Ejemplares similares
-
Postmortem toxicology findings from the Camden Opioid Research Initiative
por: Kusic, Dara M., et al.
Publicado: (2023) -
The Genomics of Opioid Addiction Longitudinal Study (GOALS): study design for a prospective evaluation of genetic and non-genetic factors for development of and recovery from opioid use disorder
por: Heil, Jessica, et al.
Publicado: (2021) -
Attitudes on Methadone Utilization in the Emergency Department: A Physician Cross-sectional Study
por: Heil, Jessica, et al.
Publicado: (2022) -
Common Treatment, Common Variant: Evolutionary Prediction of Functional Pharmacogenomic Variants
por: Scheinfeldt, Laura B., et al.
Publicado: (2021) -
Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders
por: Burns, Jamie A., et al.
Publicado: (2019)